Epidermal growth factor receptor mutation subtype has differential effects on adjuvant chemotherapy for resected adenocarcinoma pathological stages II–III

The aim of the present study was to investigate epidermal growth factor receptor (EGFR) mutations as a prognostic factor for postoperative patients with positive EGFR mutations treated with postoperative platinum-based adjuvant chemotherapy (PBAC), and whether two common EGFR mutations exhibit diffe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncol Lett
Main Authors: Kawaguchi, Yohei, Okano, Tetsuya, Imai, Kentaro, Maehara, Sachio, Maeda, Junichi, Yoshida, Koichi, Hagiwara, Masaru, Kakihana, Masatoshi, Kajiwara, Naohiro, Ohira, Tatsuo, Matsubayashi, Jun, Ikeda, Norihiko
Formato: Artigo
Idioma:Inglês
Publicado: D.A. Spandidos 2019
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6876293/
https://ncbi.nlm.nih.gov/pubmed/31807168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.11050
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares